Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

325.62 +12.90 (+4.13%)
Official Closing Price Updated: 7:00 PM EDT, Jun 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Biotech Stocks Cruise Through The Volatility
The XLV Healthcare Select SPDR is up 10% YTD. 
Via Talk Markets
Eli Lilly's Mirikizumab Improves Fatigue in Crohn's Disease Patients
As a part of a pre-specified analysis of the Phase 2 SERENITY study, new data showed that Eli Lilly And Co's (NYSE: LLY) mirikizumab improved fatigue in... 
Via Benzinga
The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation
Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow tapered, stocks took cues from clinical readouts. 
Via Talk Markets
Exposures Product Safety
The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation
Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow tapered, stocks took cues from clinical readouts.... 
Via Benzinga
Exposures Product Safety
Hospital Pharmaceuticals Market Comprehensive Study Explores Huge Growth by 2026 : AztraZeneca Plc, Bristol-Myers Squibb Company, GlaxoSmithKline Plc
Edison, NJ -- (SBWIRE) -- 05/13/2021 -- The Latest business intelligence report on COVID-19 Outbreak-Global Hospital Pharmaceuticals Market released by HTF MI aims to deliver an in-depth outline... 
Via SBWire
Topics Supply Chain
Exposures COVID-19 Supply Chain
Anticancer Drugs Market SWOT Analysis by Size, Status, Development and Forecast 2020-2026
Global Anticancer Drugs Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery is latest research study released by HTF MI evaluating the market,... 
Via SBWire
Topics Supply Chain
Exposures COVID-19 Supply Chain
Autoinjectors Market worth $104.9 billion by 2025 | Key Players are AbbVie Inc. (US), Mylan (US), Eli Lilly and Company (US)
Via AB Newswire
Topics Intellectual Property
Exposures Intellectual Property
The Fight Against Alzheimer's Reaches A Moment Of Truth For Biogen, Other Biotech Stocks
The FDA will soon review aducanumab, possibly the first new Alzheimer's treatment in years. Stakes are high for Biogen stock — and other biotech stocks too. 
Via Investor's Business Daily
Exposures Product Safety
Eli Lilly's Tirzepatide Non-Inferior To Titrated Insulin Glargine In Type 2 Diabetes Patients
Eli Lilly and Co (NYSE: LLY) has reported topline data from Phase 3 SURPASS-4 clinical trial evaluating tirzepatide in adults with type 2 diabetes and increased... 
Via Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Order Flow Abounds, Voyager CEO, CMO To Depart, Decision Day For Bristol-Myers Squibb, ASCO Abstracts Move Stocks
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 19) ESSA Pharma Inc. (NASDAQ:... 
Via Benzinga
Exposures COVID-19
Why Novo Nordisk Is Still a Top Stock for 2021
This stock could be a great addition to any long-term portfolio. 
Via The Motley Fool
The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc... 
Via Benzinga
Exposures COVID-19
Lilly-Innovent's Sintilimab Plus Chemo Application For Lung Cancer Under Review With FDA
The FDA has accepted to review Innovent Biologics Inc (OTC: IVBIY) and Eli Lilly and Co's (NYSE: LLY) marketing application for sintilimab injection... 
Via Benzinga
Exposures Product Safety
Ethical Pharmaceuticals Market May Set New Growth Story : Sanofi, Teva Pharmaceutical Industries, GlaxoSmithKline, Johnson & Johnson
Stay up-to-date with Ethical Pharmaceuticals Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Topics Regulatory Compliance
Exposures Legal Regulatory
The Business Ethics Leadership Alliance Welcomes New Members, Amazon, Regeneron Pharmaceuticals, and More While Recognizing Companies and Leaders With Exceptional Impact
IQVIA, FirstEnergy Corp., Dar al Riyadh, Grupo Energia Bogota, among the latest to join the ranks of Ethisphere's 325+ member-driven Business Ethics Leadership Alliance (BELA). Seven BELA companies and... 
Via Newswire.com
Friday Of The Heavy Week
There is nothing like a pending weekend to push Wall Street into recuperation and this worked today 
Via Talk Markets
Why AbCellera Stock Crumbled Despite In-Line Royalties For Covid Drug
AbCellera stock crumbled Friday after the company guided to lower royalties from Covid treatment partner Eli Lilly in the second quarter. 
Via Investor's Business Daily
Psychedelics Move to The Forefront of Innovative Research as the FDA Approves Large-Scale Testing
Via FinancialNewsMedia
Exposures Product Safety
Injection Pen Market Boosting the Growth Worldwide : Sandoz, Novo Nordisk, GlaxoSmithKline
The latest analysis released by HTF MI on " Global Injection Pen Market Outlook 2021 Survey " results sheds light on how investment and competitive landscape is impacted due to significant changes in... 
Via SBWire
Topics Supply Chain
Exposures Supply Chain
Value Stocks 2021 - Eli Lilly And Co.
Eli Lilly’s main source of income comes from the United States, where it generates more than 57% of its revenue. The rest is coming from Europe Rest of the world, and Japan. 
Via Talk Markets
New Senior Director for Client Delivery Joins Diligent Pharma
Jennifer Sessions joins Diligent Pharma as Senior Director of Client Delivery 
Via EIN Presswire
Topics Supply Chain
Exposures Supply Chain
Lilly, MiNA Ink Broad RNA Deal Worth $1.25B
Eli Lilly and Company (NYSE: LLY) has struck a deal with MiNA Therapeutics to develop small activating RNA (saRNA) candidates against up to five... 
Via Benzinga
Biden's Budget May Boost These 3 Biotechs
It signals a big push toward curing a neurological disease with a massive market. 
Via The Motley Fool
Exposures COVID-19
Review Of Present Therapies For Covid-19
A summary of authorized drugs for Covid-19, those in development, and those that have failed. 
Via Talk Markets
Exposures COVID-19
The Past Week's Notable Insider Buys: Amphenol, Aldeyra, Werewolf Therapeutics And More
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Once again, some insiders have taken advantage of initial... 
Via Benzinga
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -... 
Via Benzinga
Exposures COVID-19 Product Safety
Breast Cancer Therapy Market Revenue, Competitive Landscape, Opportunity Assessment and Potential of the Industry by 2026
Breast Cancer Therapy Market was valued at USD 19.02 billion in 2018 and is expected to reach USD 40.47 billion by the year 2026, at a CAGR of 10.6%. 
Via SBWire
Topics Death
Exposures Death
These Top 2 Healthcare Companies Are in a Race to Riches
Which diabetes drug maker will win this photo finish for investors? 
Via The Motley Fool
Eli Lilly Under FDA Scrutiny At Its COVID-19 Drug Manufacturing Facilities Amid Staff Accusations: Reuters
Eli Lilly & Co (NYSE: LLY) employees have reportedly accused a factory executive of altering documents required by the FDA to downplay quality control... 
Via Benzinga
Exposures COVID-19 Product Safety
Why Eli Lilly Is Still a Top Stock for 2021
You might want to consider adding this pharmaceutical giant to your portfolio. 
Via The Motley Fool
< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.